EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.3100
+0.0050 (1.64%)
Oct 28, 2026, 11:19 AM AEDT
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 14.59 million as of October 29, 2026. It is the 41,285th most valuable company in the world and the 1,184th biggest in Australia. Its market cap has decreased by 90.68% in one year.
Market Cap
14.59M
Enterprise Value
4.18M
Revenue
46.28M
Global Rank
Country Rank
#1,184 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 14.59M, a decrease of -70.05%. That is a compound annual growth rate of -19.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 14.59M | -78.00% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 19.84M |
| Algorae Pharmaceuticals | 18.25M |
| Imugene | 17.63M |
| Radiopharm Theranostics | 17.35M |
| ReNerve | 15.85M |
| Patrys | 15.14M |
| Noxopharm | 15.05M |
| Ceryvyn Therapeutics | 13.68M |